The Fly Blog | Talkmarkets | Page 1
Real-Time Financial News
Contributor's Links: TheFly.com

The Fly is a leading digital publisher of real-time financial news. Our financial market experts understand that news impacting stock prices can originate from anywhere, at any time. The Fly team scours all sources of company news, from mainstream to cutting-edge, ... more

Articles

Latest Posts
1 to 16 of 3166 Posts
1 2 3 ... 198
Berkshire Hathaway Reports Q2 Net Earnings $26.3B Vs. $14.1B Last Year
Berkshire Hathaway reported second quarter net earnings of $26.3 billion, or $16,314 per Class A share equivalent, from $14.1 billion, or $8,608 per Class A share equivalent, in the year-earlier period.
Moderna COVID Vaccine Still Has 'Best-In-Class Potential,' Says Barclays
Barclays analyst Gena Wang raised the firm's price target on Moderna to $84 from $68 and keeps an Overweight rating on the shares.
Novavax Price Target Raised To $290 From $132 At H.C. Wainwright
H.C. Wainwright analyst Vernon Bernardino raised the firm's price target on Novavax to $290 from $132 and keeps a Buy rating on the shares.
JPMorgan Upgrades Novavax On Potential 'Best-In-Class' COVID Vaccine
JPMorgan analyst Eric Joseph upgraded Novavax to Overweight from Neutral with a price target of $275, up from $105.
Credit Suisse Upgrades Disney With Streaming Strategy Trumping COVID
Credit Suisse analyst Douglas Mitchelson upgraded Disney to Outperform from Neutral with a price target of $146, up from $116, following last night's fiscal Q3 results.
DBV Receives Non Approval Letter From FDA For Peanut Allergy Patch
DBV Technologies announced that the Food and Drug Administration has issued a Complete Response Letter regarding the company's Biologics License Application for Viaskin Peanut.
Street Missing 'Eye-Catching' CymaBay Data, Says Piper Sandler
August 3's topline data from CymaBay's halted Phase 3 study answered key questions for seladelpar around its effect on itch, a hallmark symptom of primary biliary cholangitis, Piper Sandler analyst Yasmeen Rahimi tells investors in a research note.
Lordstown Follows Peers' Rush To Stock Market With SPAC Merger
Shares of special purpose acquisition company, or SPAC, DiamondPeak Holdings jumped on Monday, after the company announced that it is merging with Lordstown Motors, with the combined entity to trade on the Nasdaq under the symbol "RIDE."
Siemens Healthineers Acquires Varian For $177.50 Per Share Or $16.4 Billion
Varian announced that it has entered into a definitive agreement to combine with Siemens Healthineers in an all-cash transaction valued at $16.4 billion on a fully diluted basis.
Kansas City Southern Jumps After WSJ Says PE Firms Discussing Bid
Shares of Kansas City Southern jumped after the Wall Street Journal reported that Blackstone Group and Global Infrastructure Partners are considering a takeover bid for the railroad operator that could be worth more than $21 billion.
The Trump Effect: How Trump's Policies Moved Stocks This Past Week
Trump says drug prices to be "lowered massively," Chinese-backed hackers reportedly behind Moderna attack.
Deutsche Ups Amazon Target To $4,000, Sees Over 2 Trillion Valuation
Deutsche Bank analyst Lloyd Walmsley raised the firm's price target on Amazon.com to $4,000 from $3,333 and reiterates a Buy rating on the shares following last night's "blowout quarter."
Apple Price Target Raised To $450 From $310 At Piper Sandler
Piper Sandler analyst Harsh Kumar raised the firm's price target on Apple to $450 from $310 and reiterates an Overweight rating on the shares.
Citi Downgrades L Brands To Sell After 35% Post-Earnings Rally
Citi analyst Paul Lejuez downgraded L Brands to Sell from Neutral with a price target of $17, up from $15.
Alkermes Downgraded To Sell From Neutral At Goldman Sachs
Goldman Sachs analyst Terence Flynn downgraded Alkermes to Sell from Neutral with a price target of $15, down from $19.
Oppenheimer Upgrades Milestone To Outperform On 'Best-Case' FDA Outcome
Oppenheimer analyst Leland Gershell upgraded Milestone Pharmaceuticals to Outperform from Perform with an $18 price target.
1 to 16 of 3166 Posts
1 2 3 ... 198